Post-market, European study to assess the safety and performance of IVL as standalone therapy in heavily calcified infrapopliteal lesions out to 30 days.
Shockwave S4: Addressing the Challenges of Calcified Below-the-Knee Disease
Dr. Melissa Loja shares her thoughts on IVL for the treatment of calcified infrapopliteal lesions and why she turns to Shockwave S4 for her most challenging cases.